Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: A comparison with angiopoietin/Tie pathway

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 379-386

  Dhar, Dipok Kumar ^a   Naora, Hiroyuki ^a   Yamanoi, Akira ^a   Ono, Takashi ^a   Kohno, Hitoshi ^a   Otani, Hiroki ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiopoietin; Hepatocellular cancer; Prognosis; Tie; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; ENDOGLIN; MESSENGER RNA; PROTEIN; PROTEIN TIE; TIE 1 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANGIOPOIETIN-1; ANTIGENS, CD31; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-1; RECEPTORS, GROWTH FACTOR; RECEPTORS, TIE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER;

EID: 0036254553     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. What is the evidence that tumors are angiogenesis dependent?
2. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
3. Tumor vascularity predicts recurrence in differentiated thyroid carcinoma
4. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus
5. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma
6. Distribution of vascular permeability factor(vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
7. Expression of vascular permeability factor(vascular endothelial growth factor) and its receptors in breast cancer
8. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
9. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
10. Identification of a new endothelial cell growth factor receptor tyrosine kinase
11. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
12. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
13. Expression of Tie/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis
14. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance
15. Liver resection for hepatocellular carcinoma: Results of 229 consecutive patients during 11 years
16. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular, carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
17. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
18. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
19. Expression of vascular endothelial growth factor in human hepatocellular carcinoma
20. Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens
21. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues
22. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
23. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
24. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
25. Expression of fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
26. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
27. Expression of vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and vascular tumors
28. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
29. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
30. Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma
31. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2(Flk1) and VEGF receptor 3 (Flt4)
32. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
33. Enhanced expression of the Tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas
34. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo